I agree that this site is using cookies. You can find further informations here.
X
Abdul Rafeh Naqash, MD
56  results:
Search for persons X
?
1

Association Between Immune-Related Adverse Events and Clini..:

Biagio Ricciuti, MD ; Abdul Rafeh Naqash, MD ; Jarushka Naidoo, MD...
http://www.sciencedirect.com/science/article/pii/S2666364320300977.  , 2020
Link: https://doi.org/10.1016/..
 
?
2

Molecular Characterization of TFE3-Rearranged Renal Cell Ca..:

Wei, Shuanzeng ; Krause, Harris B. ; Geynisman, Daniel M....
Modern Pathology.  37 (2024)  2 - p. 100404 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Exploring the Landscape of Immune Checkpoint Inhibitor-Indu..:

Fadlullah, Muhammad Zaki Hidayatullah ; Lin, Ching-Nung ; Coleman, Samuel...
The Oncologist.  29 (2024)  5 - p. 415-421 , 2024
Link: https://doi.org/10.1093/..
 
?
4

Accurately addressing double-arm-zero-events studies in met..:

Fujiwara, Yu ; Horita, Nobuyuki ; Naqash, Abdul Rafeh
The Lancet Oncology.  25 (2024)  3 - p. e93 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Real-World Multicenter Study of PD-1 Blockade in HIV-Associ..:

Lurain, Kathryn ; Zarif, Talal El ; Ramaswami, Ramya...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  8 - p. 523-530 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Clinical outcomes and safety of immune checkpoint inhibitor..:

Nassar, Amin H ; El Zarif, Talal ; Khalid, Ahmed Bilal...
Journal for ImmunoTherapy of Cancer.  12 (2024)  3 - p. e008724 , 2024
Link: https://doi.org/10.1136/..
 
?
7

Treatment-related adverse events, including fatal toxicitie..:

Fujiwara, Yu ; Horita, Nobuyuki ; Adib, Elio...
The Lancet Oncology.  25 (2024)  1 - p. 62-75 , 2024
Link: https://doi.org/10.1016/..
 
?
8

THU-464 aMAP score predicts progression-free survival in pa..:

Vithayathil, Mathew ; D'Alessio, Antonio ; Fulgenzi, Claudia...
Journal of Hepatology.  80 (2024)  - p. S443 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Benchmarking mismatch repair testing for patients with canc..:

Bou Farhat, Elias ; Adib, Elio ; Daou, Melissa...
Cancer Cell.  42 (2024)  2 - p. 323 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Response letter by Nassar et al:

Nassar, Amin H. ; Kim, So Yeon ; Adib, Elio..
Journal of Thoracic Oncology.  19 (2024)  5 - p. e7-e8 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Emerging advances in defining the molecular and therapeutic..:

Sen, Triparna ; Takahashi, Nobuyuki ; Chakraborty, Subhamoy...
Nature Reviews Clinical Oncology.  , 2024
Link: https://doi.org/10.1038/..
 
?
12

Increasing diversity in clinical trials: demographic trends..:

Choradia, Nirmal ; Karzai, Fatima ; Nipp, Ryan...
JNCI: Journal of the National Cancer Institute.  116 (2024)  7 - p. 1063-1071 , 2024
Link: https://doi.org/10.1093/..
 
?
13

Benchmarking mismatch repair testing for patients with canc..:

Bou Farhat, Elias ; Adib, Elio ; Daou, Melissa...
Cancer Cell.  42 (2024)  1 - p. 6-7 , 2024
Link: https://doi.org/10.1016/..
 
?
14

The Effect of Sodium-Glucose Cotransporter-2 Inhibitors on ..:

Agarwal, Siddharth ; Qamar, Usama ; Fujiwara, Yu...
The American Journal of Cardiology.  216 (2024)  - p. 87-90 , 2024
Link: https://doi.org/10.1016/..
 
?
15

Progression patterns and therapeutic sequencing following i..:

Talbot, Thomas ; D'Alessio, Antonio ; Pinter, Matthias...
Liver International.  43 (2023)  3 - p. 695-707 , 2023
Link: https://doi.org/10.1111/..
 
1-15